LAVAL, QC, June 21, 2021 /PRNewswire/ -- Bausch Health
Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company")
today announced that D. Robert
Hale has resigned from his role as an independent director
of the Company's Board of Directors ("Board") to focus on other
business obligations related to his firm, ValueAct Capital
("ValueAct"), a shareholder of the Company.
"Rob has been a valued member of our Board since 2015, including
formerly serving as our Chair of the Finance and Transactions
Committee and as a member of the Talent and Compensation Committee,
and most recently serving on the Special Transaction Committee. I
would like to express my gratitude to ValueAct and to Rob for his
numerous contributions, particularly as we have continued to
transform Bausch Health," said Joseph C.
Papa, chairman and CEO, Bausch
Health. "As we continue to work to execute the spinoff of
Bausch + Lomb and create two attractive businesses to unlock value,
we are focused on forming two strong Boards with diverse
representation and perspectives to ensure we represent the
customers, patients and shareholders we serve around the
world."
The Company and entire Board would like to thank Mr. Hale for
his services and contributions and wish him well in his future
endeavors.
"It has been a privilege to serve on the Bausch Health Board
under Joe's leadership as he and the executive team transformed the
Company in line with a mission to improve people's lives with the
Company's health care products. With my increasing professional
responsibilities outside of Bausch Health, including joining the
board of a second company headquartered in Japan last week, and considering my capable
colleagues on the Board representing all of Bausch Health's
shareholders, I am resigning my seat," said D. Robert Hale.
"I fully support the Company's strategy to separate the global
eye health business, its efforts to accelerate this strategy, and
the ongoing leadership selection process. ValueAct remains an
engaged and supportive shareholder. We are excited for what's
ahead," Mr. Hale continued.
About Bausch Health
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology, and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. For more information, visit
www.bauschhealth.com and connect with us on Twitter and
LinkedIn.
Forward-looking Statements
This news release may
contain forward-looking statements, which may generally be
identified by the use of the words
"anticipates," "expects," "intends," "plans," "should," "could," "would," "may,"
"believes," "estimates," "potential," "target," or "continue" and
variations or similar expressions. These statements are based upon
the current expectations and beliefs of management and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, but are not
limited to, the risks and uncertainties discussed in Bausch
Health's most recent annual report on Form 10-K and detailed from
time to time in Bausch Health's other filings with the U.S.
Securities and Exchange Commission and the Canadian Securities
Administrators, which factors are incorporated herein by reference.
They also include, but are not limited to, risks and uncertainties
caused by or relating to the evolving COVID-19 pandemic, and the
fear of that pandemic and its potential effects, the severity,
duration and future impact of which are highly uncertain and cannot
be predicted, and which may have a material adverse impact on
Bausch Health, including but not limited to its project development
timelines, and costs (which may increase). Readers are cautioned
not to place undue reliance on any of these forward-looking
statements. These forward-looking statements speak only as of the
date hereof. Bausch Health undertakes no obligation to update any
of these forward-looking statements to reflect events or
circumstances after the date of this news release or to reflect
actual outcomes, unless required by law.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
(514)
856-3855
|
(908)
927-1198
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bausch-health-announces-d-robert-hale-has-resigned-from-its-board-of-directors-301316127.html
SOURCE Bausch Health Companies Inc.